March 06, 2026 11:04 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Guest of India struck in international waters': Iran furious after US submarine torpedoes IRIS Dena | Bihar's 'Susashan Babu' Nitish Kumar announces exit as CM, set for Rajya Sabha debut | ‘Baseless’: India rejects claims US used its ports to strike Iran | Defiant silence: Iran women’s team refuses anthem days after Khamenei’s death | 'You’ll find out soon': Trump hints at massive retaliation after Riyadh attack, says ‘boots on ground’ may not be needed | Iran claims Netanyahu's office targeted in 'surprise missile attacks' | India, Canada to host renewable energy summit as Modi, Carney push to deepen bilateral ties | Gold, silver surge as Middle East conflict sparks safe-haven buying | Middle East tension: Several US warplanes crash in Kuwait, says Defence Ministry | Indian defence shares jump as West Asia conflict triggers investor rush

'Make in India' initiative partners with BioAsia 2016

| | Jan 20, 2016, at 12:44 am
New Delhi, Jan 19 (IBNS) BioAsia, Asia's biggest technology and bio-business platform, has on Tuesday announced that the Make in India initiative by Government of India has partnered with the 13th edition of BioAsia to be held in Hyderabad from Feb 8 to Feb 10.

The partnership will make BioAsia the only BioPharma event to associate with this ambitious initiative of the Government of India. ‘Make in India’ partnership will also enhance the level of the impact of the deliberations at the event, given that the relevant policy makers will be attendance at the event, to interact and engage with the industry and academic stakeholder.

India is among the countries considered as likely to have the strongest gains in developing next generation life-saving products in the coming decade. Recognizing this opportunity and rightly so, Government of India through its ‘Make in India’ initiative has attached ample emphasis on the pharmaceuticals and biotechnology sectors to fortify the country manufacturing ecosystem, to enhance development of skills, nurture a conducive regulatory environment, foster innovation and protect intellectual property.

The initiative aims to encourage not only global companies to invest in India, but also enliven domestic players to increase their size. Complementing the Make in India initiative is the Telangana Government’s first-of-its-kind Pharma City, spread across 15,000 acres and at par with international standards.

Under this context, CEO Conclave of this edition of BioAsia will focus on “Make in India - Flavors of policy change”.

The conclave will elicit thought provoking discussions on the opportunities and challenges for the sector under the Make in India program, besides proposing various policy measures that can accelerate the growth of life sciences sector in India.

Shakthi Nagappan, CEO – BioAsia, while commenting on the partnership with Make in India, said, “Make in India’s partnership with BioAsia is a testimony to the value that BioAsia has created for the life sciences industry over the last 12 years. We are sure that focused sessions around Make in India at BioAsia 2016 will add immense value to the all participants especially the pharma and biotech manufacturers”
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Videos
RBI announces repo rate cut Jun 06, 2025, at 10:51 am
FM Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:45 pm
Nirmala Sitharaman on Budget 2024 Jul 23, 2024, at 09:30 pm